Johnson & Johnson To Oversee Vaccine Production At Baltimore Facility

Content Curator
Johnson & Johnson will oversee all aspects of vaccine production at the Emergent BioSolutions facility in Baltimore. The Biden administration and the Department of Health and Human Services facilitated the change in management.

The site was producing substances for both the Johnson & Johnson and AstraZeneca vaccines. But following a mix-up, the facility will focus solely on producing ingredients for the J&J vaccine.

(Image credit: Stephen Zenner/Getty Images)